Shenyang Dongxin Pharmaceutical Co., Ltd. Sustainability Profile
Shenyang Dongxin Pharmaceutical Co., Ltd., commonly referred to as Dongxin Pharma, is a prominent player in the pharmaceutical industry, headquartered in Shenyang, China. Established in 1995, the company has made significant strides in the development and manufacturing of high-quality pharmaceutical products, particularly in the fields of antibiotics and cardiovascular medications. With a strong operational presence across various regions in China, Dongxin Pharma is renowned for its commitment to innovation and quality. The company’s core offerings include a diverse range of generic drugs and active pharmaceutical ingredients (APIs), distinguished by their efficacy and safety. Dongxin Pharma has achieved notable recognition in the market, positioning itself as a trusted name in the pharmaceutical sector, dedicated to improving healthcare outcomes.
DitchCarbon Score
How does Shenyang Dongxin Pharmaceutical Co., Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Retail Trade Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Shenyang Dongxin Pharmaceutical Co., Ltd.'s score of 20 is lower than 83% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Shenyang Dongxin Pharmaceutical Co., Ltd.'s reported carbon emissions
Shenyang Dongxin Pharmaceutical Co., Ltd., headquartered in CN, currently does not have available emissions data for the most recent year. As a result, specific figures regarding their carbon emissions, including Scope 1, Scope 2, and Scope 3 totals, are not provided. Additionally, there are no documented reduction targets or climate pledges from the company, indicating a lack of formal commitments to reduce carbon emissions at this time. The absence of emissions data and reduction initiatives suggests that Shenyang Dongxin Pharmaceutical may still be in the early stages of developing a comprehensive climate strategy. In the context of the pharmaceutical industry, companies are increasingly expected to adopt robust climate commitments and transparency regarding their emissions. As such, Shenyang Dongxin Pharmaceutical may benefit from establishing clear targets and reporting mechanisms to align with industry standards and stakeholder expectations.
How Carbon Intensive is Shenyang Dongxin Pharmaceutical Co., Ltd.'s Industry?
How Carbon Intensive is Shenyang Dongxin Pharmaceutical Co., Ltd.'s Location?
Shenyang Dongxin Pharmaceutical Co., Ltd.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Shenyang Dongxin Pharmaceutical Co., Ltd. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.
Jiangxi Tengwangge Pharmaceutical Co., Ltd.
Jiang Zhong Pharmaceutical Co.,Ltd
Let us know if this data was useful to you
Usage Policy
You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.